Show simple item record

dc.contributor.author Jaber, Samer
dc.date.accessioned 2021-12-23T13:21:47Z
dc.date.available 2021-12-23T13:21:47Z
dc.date.issued 2014
dc.identifier.citation JABER, Samer. Clinical and biological features in chronic hepatitis D. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, pp. 95-96. en_US
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/19530
dc.description Department of Gastroenterology, State Medical and Pharmaceutical University “Nicolae Testemi|anu“, Chișinău, Republic of Moldova en_US
dc.description.abstract Introduction: Infection with hepatitis D virus (HDV) has a worldwide distribution, but areas of high prevalence include the Mediterranean Basin, inclusively Moldova. Most of the patients have progressive deterioration of liver function and increased risk of liver cirrhosis and end-stage of liver failure. Purpose and objectives: To evaluate clinical features, paraclinical results and laboratory peculiarities of liver function in patients with chronic hepatitis D, in comparison with chronic hepatitis B patients. Material and methods: Thirty-six patients, twenty with chronic HDV infection, with median age of 40.2 years, and other 16 with chronic HBV infection, with median age of 43,3 years, were investigated consecutively. Results: The clinical presentation of patients with chronic hepatitis D shows the predominance of astheno-vegetative syndrome (100%), dull pain in right upper quadrant (83%), hepatomegaly (60%) and splenomegaly (33%). In patients with HDV was found veridical pronounced cytolytic syndrome, manifested by increase of ALT (97.55+8.5 U/l) and AST (78.83+6.2 U/l) compared with control group (p<0.001) and patients with HBV (p<0.05), also was determined tendency towards reduction of prothrombin and albumin compared with chronic hepatitis B. Research blood count revealed a white blood cell (3.6+0.57 x 109/1) and platelet counts (156.8+10.2 x 109/1) decreased truthful in HDV versus the control group (p<0.01), as well as to patients with HBV (p<0.05). In HDV patients we have detected the presence of HBsAg, anti-HBcor and anti-HDV in all patients (100%), HBeAg - in 30% of patients, anti-HBe - in 70%. The HDV RNA was found present in all investigated patients with chronic hepatitis D, a low titre of HBV DNA was detected in 5 (25%) patients. Chronic hepatitis D patients had high viral level of HDV RNA, on average of 514038 IU/ml. Most of them had a negative HBV DNA - 76%, and just 24% had parallel HBV DNA and HDV RNA. Conclusions: In patients with HDV infection was observed a higher frequency of clinical and paraclinical symptoms versus HBV alone, a more evident cytolytic syndrome, leukopenia and thrombocytopenia, (p<0.01). The majority of patients with chronic hepatitis D, have high viral level of HDV RNA, and therefore they require antiviral treatment. en_US
dc.language.iso en en_US
dc.publisher Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association en_US
dc.relation.ispartof MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova en_US
dc.subject Chronic hepatitis Delta en_US
dc.subject treatment en_US
dc.subject antiviral en_US
dc.title Clinical and biological features in chronic hepatitis D en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2014
    The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics